Published on 5 May 2023 on Simply Wall St. via Yahoo Finance
With a price-to-sales (or "P/S") ratio of 4.2x Alector, Inc. (NASDAQ:ALEC) may be sending very bullish signals at the moment, given that almost half of all the Biotechs companies in the United States have P/S ratios greater than 11.5x and even P/S higher than 53x are not unusual. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly reduced P/S.
Check out our latest analysis for Alector
ps-multiple-vs-industry